공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 나노의학(Nanomedicine) 시장 규모 조사 : 모달리티별, 애플리케이션별, 적응증별, 지역별 예측(2020-2027년)

Global Nanomedicine Market Size study, by Modality, by Application, by Indication and Regional Forecasts 2020-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2021년 02월 상품 코드 988171
페이지 정보 영문
가격
US $ 4,950 ₩ 5,594,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,064,000 Printable PDF (Enterprise License)


세계의 나노의학(Nanomedicine) 시장 규모 조사 : 모달리티별, 애플리케이션별, 적응증별, 지역별 예측(2020-2027년) Global Nanomedicine Market Size study, by Modality, by Application, by Indication and Regional Forecasts 2020-2027
발행일 : 2021년 02월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 나노의학(Nanomedicine) 시장 규모는 2019년에 약 1,600억 달러를 기록했으며, 2020-2027년의 예측 기간 중 12.6%를 넘는 성장률로 성장할 것으로 예상되고 있습니다.

나노의학은 생물학적 시스템의 치료·진단·제어 및 감시에 사용되는 나노테크놀러지의 가장 중요한 애플리케이션의 하나입니다. 나노의학은 재료의 나노스케일 조작을 이용하여 의약품 전달을 강화합니다. 이와 같이 나노의학은 암, 심혈관질환 등 다양한 질병의 치료를 가능하게 했습니다.

나노의학은 암의 가장 유망한 치료법입니다. 나노의학은 암의 개선된 맞춤형 치료를 추진하기 위해 이용할 수 있습니다. 나노의학은 일반 치료법보다 큰 유효성과 부작용이 적은 혁신적인 약을 작성할 수 있습니다. 따라서 암의 유병률 급증은 전 세계 시장의 성장을 위한 주요 촉진요인으로 기능할 가능성이 있습니다. 그러나 제품 승인을 위한 엄격한 정부 기준과 나노의학의 고비용은 2020-2027년의 예측 기간 중 시장의 성장을 저해하는 몇개의 주요 요인입니다.

나노의학 시장을 조사했으며, 시장 개요, 시장 성장요인 및 저해요인 분석, 모달리티별, 애플리케이션별, 적응증별, 지역별 시장 규모의 추이와 예측, 경쟁 구도, 주요 기업의 개요, 시장 기회 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 세계 나노의학 시장의 정의와 범위

제3장 세계의 나노의학 시장 역학

  • 나노의학 시장의 영향 분석

제4장 세계의 나노의학 시장 산업 분석

  • Porter의 산업 분석
  • PEST 분석
  • 투자 채택 모델
  • 애널리스트의 추천 사항과 결론

제5장 모달리티별 세계의 나노의학 시장

  • 시장 스냅숏
  • 모달리티별 세계의 나노의학 시장 - 잠재적 분석
  • 모달리티별 세계의 나노의학 시장 추산과 예측
  • 나노의학 시장 : 하위 부문 분석
    • 진단
    • 치료

제6장 애플리케이션별 세계의 나노의학 시장

  • 시장 스냅숏
  • 애플리케이션별 세계의 나노의학 시장 - 잠재적 분석
  • 애플리케이션별 세계의 나노의학 시장 추산과 예측
  • 나노의학 시장 : 하위 부문 분석
    • 약물전달
    • 백신
    • 영상 진단
    • 재생의료
    • 임플란트
    • 기타

제7장 적응증별 세계의 나노의학 시장

  • 시장 스냅숏
  • 적응증별 세계의 나노의학 시장 - 잠재적 분석
  • 적응증별 세계의 나노의학 시장 추산과 예측
  • 나노의학 시장 : 하위 부문 분석
    • 종양성 질환
    • 감염증
    • 심혈관질환
    • 정형외과 장애
    • 신경질환
    • 기타

제8장 세계의 나노의학 시장 : 지역별 분석

  • 지역 시장 스냅숏
  • 북미
    • 미국
    • 캐나다
  • 유럽 스냅숏
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양 스냅숏
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카 스냅숏
    • 브라질
    • 멕시코
  • 기타 지역

제9장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Abbott Laboratories
    • CombiMatrix Corp.
    • General Electric
    • Johnson & Johnson
    • Mallinckrodt Pharmaceuticals
    • Merck & Co., Inc.
    • Luminex Corporation
    • Pfizer Inc.
    • Leadiant Biosciences, Inc.
    • Teva Pharmaceutical Industries Ltd.

제10장 조사 프로세스

KSA 21.02.19

LIST OF TABLES

  • TABLE 1. Global Nanomedicine market, report scope
  • TABLE 2. Global Nanomedicine market estimates & forecasts by region 2017-2027 (USD Billion)
  • TABLE 3. Global Nanomedicine market estimates & forecasts by Modality 2017-2027 (USD Billion)
  • TABLE 4. Global Nanomedicine market estimates & forecasts by Application 2017-2027 (USD Billion)
  • TABLE 5. Global Nanomedicine market estimates & forecasts by Indication 2017-2027 (USD Billion)
  • TABLE 6. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 19. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Global Nanomedicine market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. Global Nanomedicine market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 22. U.S. Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 23. U.S. Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 24. U.S. Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 25. Canada Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 26. Canada Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 27. Canada Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 28. UK Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 29. UK Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. UK Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 31. Germany Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 32. Germany Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 33. Germany Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 34. France Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 35. France Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. France Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 37. Spain Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 38. Spain Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. Spain Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 40. Italy Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 41. Italy Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. Italy Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. ROE Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 44. ROE Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 45. ROE Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. China Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 47. China Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. China Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 49. India Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 50. India Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. India Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 52. Japan Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 53. Japan Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Japan Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. Australia Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 56. Australia Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 57. Australia Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 58. South Korea Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 59. South Korea Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 60. South Korea Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 61. ROPAC Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 62. ROPAC Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 63. ROPAC Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 64. Brazil Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 65. Brazil Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 66. Brazil Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 67. Mexico Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 68. Mexico Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 69. Mexico Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 70. ROLA Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 71. ROLA Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 72. ROLA Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 73. ROW Nanomedicine market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 74. ROW Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 75. ROW Nanomedicine market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 76. List of secondary sources, used in the study of global Nanomedicine market
  • TABLE 77. List of primary sources, used in the study of global Nanomedicine market
  • TABLE 78. Years considered for the study
  • TABLE 79. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Nanomedicine market, research methodology
  • FIG 2. Global Nanomedicine market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Nanomedicine market, key trends 2019
  • FIG 5. Global Nanomedicine market, growth prospects 2020-2027
  • FIG 6. Global Nanomedicine market, porters 5 force Model
  • FIG 7. Global Nanomedicine market, pest analysis
  • FIG 8. Global Nanomedicine market, value chain analysis
  • FIG 9. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Nanomedicine market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Nanomedicine market, regional snapshot 2017 & 2027
  • FIG 18. North America Nanomedicine market 2017 & 2027 (USD Billion)
  • FIG 19. Europe Nanomedicine market 2017 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Nanomedicine market 2017 & 2027 (USD Billion)
  • FIG 21. Latin America Nanomedicine market 2017 & 2027 (USD Billion)
  • FIG 22. Global Nanomedicine market, company market share analysis (2019)

Title:
Global Nanomedicine Market Size study, by Modality (Diagnostics, Treatments), by Application (Drug Delivery, Vaccines, Diagnostic Imaging, Regenerative Medicine, Implants, Others), by Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Diseases, Others) and Regional Forecasts 2020-2027.

Global Nanomedicine Market is valued at approximately USD 160 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.6% over the forecast period 2020-2027. Nanomedicine is one of the most significant applications of nanotechnology used in the treatment, diagnosis, control, and monitoring of biological systems. Nanomedicine utilizes nanoscale manipulation of materials to enhance medicine delivery. Thus, nanomedicine has enabled the treatment alongside various diseases, such as cancer, cardiovascular diseases, and so on. Nanomedicine is the most promising mode of treatment of cancer. This expanding field of medical research can be utilized to discover improved personalized treatment for cancer in the present scenario. With the benefit of the properties of issue at nanoscale, nanomedicine pledges to create innovative drugs with larger efficacy and reduced side-effects than regular therapies. Thus, the surge in prevalence of cancer may act as a major driving factor for the growth of the market all over the world. According to the National Cancer Institute (NIH), the prevalence of cancer has a major impact on society in the world and across the United States. As of January 2019, around 16.9 million cancer survivors were reported in the United States and is projected to increase to almost 22.2 million by the year 2030. Also, in 2020, an estimated 1,806,590 new cases of cancer were found and will be diagnosed in the United States. Furthermore, the rise in government approvals for the products developed by the manufacturers, along with the increased emergence of newer technologies for drug delivery are the few factors responsible for the high CAGR of the market during the forecast period. For instance, in February 2017, the Celgene International Sarl granted approval for its REVLIMID (lenalidomide) from the European Commission, as monotherapy for patient's treatment with multiple myeloma. This, in turn, is expected to strengthen the market growth all over the world. However, the high cost of nanomedicine, coupled with strict government norms for product approval are the few major factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Nanomedicine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in government funding for the nanoscale technology and nanomedicine, and the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of chronic diseases such as cancer, along with the increasing number of venture capital investors in developing countries, such as China and India, would create lucrative growth prospects for the Nanomedicine market across the Asia-Pacific region.

Major market player included in this report are:

Abbott Laboratories

CombiMatrix Corp.

General Electric

Johnson & Johnson

Mallinckrodt Pharmaceuticals

Merck & Co., Inc.

Luminex Corporation

Pfizer Inc.

Leadiant Biosciences, Inc.

Teva Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Modality:

Diagnostics

Treatments

By Application:

Drug Delivery

Vaccines

Diagnostic Imaging

Regenerative Medicine

Implants

Others

By Indication:

Oncological Diseases

Infectious Diseases

Cardiovascular Diseases

Orthopedic Disorders

Neurological Diseases

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Nanomedicine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Nanomedicine Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Nanomedicine Market, by Modality, 2018-2027 (USD Billion)
    • 1.2.3. Nanomedicine Market, by Application, 2018-2027 (USD Billion)
    • 1.2.4. Nanomedicine Market, by Indication, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Nanomedicine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Nanomedicine Market Dynamics

  • 3.1. Nanomedicine Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Nanomedicine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Nanomedicine Market, by Modality

  • 5.1. Market Snapshot
  • 5.2. Global Nanomedicine Market by Modality, Performance - Potential Analysis
  • 5.3. Global Nanomedicine Market Estimates & Forecasts by Modality 2017-2027 (USD Billion)
  • 5.4. Nanomedicine Market, Sub Segment Analysis
    • 5.4.1. Diagnostics
    • 5.4.2. Treatments

Chapter 6. Global Nanomedicine Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Nanomedicine Market by Application, Performance - Potential Analysis
  • 6.3. Global Nanomedicine Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
  • 6.4. Nanomedicine Market, Sub Segment Analysis
    • 6.4.1. Drug Delivery
    • 6.4.2. Vaccines
    • 6.4.3. Diagnostic Imaging
    • 6.4.4. Regenerative Medicine
    • 6.4.5. Implants
    • 6.4.6. Others

Chapter 7. Global Nanomedicine Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Nanomedicine Market by Indication - Potential Analysis
  • 7.3. Global Nanomedicine Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)
  • 7.4. Nanomedicine Market, Sub Segment Analysis
    • 7.4.1. Oncological Diseases
    • 7.4.2. Infectious Diseases
    • 7.4.3. Cardiovascular Diseases
    • 7.4.4. Orthopedic Disorders
    • 7.4.5. Neurological Diseases
    • 7.4.6. Others

Chapter 8. Global Nanomedicine Market, Regional Analysis

  • 8.1. Nanomedicine Market, Regional Market Snapshot
  • 8.2. North America Nanomedicine Market
    • 8.2.1. U.S. Nanomedicine Market
      • 8.2.1.1. Modality breakdown estimates & forecasts, 2017-2027
      • 8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. Indication breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada Nanomedicine Market
  • 8.3. Europe Nanomedicine Market Snapshot
    • 8.3.1. U.K. Nanomedicine Market
    • 8.3.2. Germany Nanomedicine Market
    • 8.3.3. France Nanomedicine Market
    • 8.3.4. Spain Nanomedicine Market
    • 8.3.5. Italy Nanomedicine Market
    • 8.3.6. Rest of Europe Nanomedicine Market
  • 8.4. Asia-Pacific Nanomedicine Market Snapshot
    • 8.4.1. China Nanomedicine Market
    • 8.4.2. India Nanomedicine Market
    • 8.4.3. Japan Nanomedicine Market
    • 8.4.4. Australia Nanomedicine Market
    • 8.4.5. South Korea Nanomedicine Market
    • 8.4.6. Rest of Asia Pacific Nanomedicine Market
  • 8.5. Latin America Nanomedicine Market Snapshot
    • 8.5.1. Brazil Nanomedicine Market
    • 8.5.2. Mexico Nanomedicine Market
  • 8.6. Rest of The World Nanomedicine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. CombiMatrix Corp.
    • 9.2.3. General Electric
    • 9.2.4. Johnson & Johnson
    • 9.2.5. Mallinckrodt Pharmaceuticals
    • 9.2.6. Merck & Co., Inc.
    • 9.2.7. Luminex Corporation
    • 9.2.8. Pfizer Inc.
    • 9.2.9. Leadiant Biosciences, Inc.
    • 9.2.10. Teva Pharmaceutical Industries Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
Back to Top
전화 문의
F A Q